Arginine in food supplements
1,628 supplements declared in France contain Arginine as a substance or active ingredient.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
In plain words
À quoi il sert, selon les fabricants
Objectives most often stated for supplements that contain it (Arginine): sport (447 produits), tonus sexuel (265 produits), cheveux et ongles (142 produits), peau (65 produits), immunité (55 produits).
These are the objectives manufacturers declared to the authorities, not proven effects. On the packaging, only health claims authorised by the EU may be written.
Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
What health agencies say
An opinion says what the agency recommends; it is not a rule binding on the product.
ANSES states that arginine supplements are contraindicated in people who have previously had a myocardial infarction. It also notes that their effects on lowering blood pressure and dilating blood vessels can add to those of certain medicines.
Declared daily quantities
| Unit | Products | Median | Minimum | Maximum |
|---|---|---|---|---|
| mg | 277 | 200 | 5 | 6,000 |
Calculated from Compl'Alim declarations that provide a quantity. These are quantities declared by manufacturers, not measurements, and preparation is not distinguished (powder, extract of varying concentration): differences between products can be very large.
Official warnings (Health Canada)
L-ARGININE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are pregnant or breastfeeding.
Condition of application: Improvement in exercise capacity in individuals with stable CVD.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician if your symptoms worsen.
Applies to products providing more than 0.42 g of L-Arginine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you have a cardiovascular disease and are attempting an increase in physical activity (Doutreleau et al. 2010; Doutreleau et al. 2006; Schulman et al. 2006; Goldman and Ausiello 2004; Nagaya et al. 2001; Bednarz et al. 2000; Ceremużyński et al. 1997; Rector et al. 1996).
Sources cited by Health Canada (7)
- Bednarz B, Wolk R, Chamiec T, Herbaczyńska-Cedro K, Winek D, Ceremużyński L. Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. International Journal of Cardiology 2000;75(2-3):205-210. PubMed Randomised trial
- Ceremużyński L, Chamiec T, Herbaczyńska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. The American Journal of Cardiology 1997;80(3):331-333. PubMed Randomised trial
- Doutreleau S, Rouyer O, Di Marco P, Lonsdorfer E, Richard R, Piquard F, Geny B. L-Arginine supplementation improves exercise capacity after a heart transplant. American Journal of Clinical Nutrition. 2010. Doi: 10.3945/ajcn.2009.27881. DOI
- Doutreleau S, Mettauer B, Piquard F, Rouyer O, Schaefer A, Lonsdorfer J., Beny B. Chronic L-Arginine Supplementation Enhances Endurance Exercise Tolerance in Heart Failure Patients. International Journal of Sports Medicine 2006;27(7):567-572. PubMed
- Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, Ueno K, Nakanishi N, Yamagishi M, Miyatake K. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2001;163(4):887-891. PubMed Randomised trial
- Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH. Randomized, double-blind, placebo-controlled study of supplemental oral –arginine in patients with heart failure. Circulation 1996;93(12):2135-2141. PubMed Randomised trial
- Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G. L-Arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomised clinical trial. Journal of American Medical Association 2006;295(1):58-64. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners (Huynh et al. 2002; Parker et al. 2002; Siani et al. 2000; Adams et al. 1995).
Sources cited by Health Canada (4)
- Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. Journal of the American College of Cardiology 1995;26(4):1054-1061. PubMed Randomised trial
- Huynh NT, Tayek JA. Oral arginine reduces systemic blood pressure in type 2 diabetes: Its potential role in nitric oxide generation. American College of Nutrition 2002;21(5):422-427. PubMed Clinical trial
- Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. Journal of the American College of Cardiology 2002;39(7):1199-1203. PubMed Randomised trial
- Siani A, Pagano E, Iacone R, Iacoviello L, Scopacasa F, Strazzullo P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. American Journal of Hypertension 2000;13(5):547-551. PubMed Randomised trial
Contraindications
Applies to products providing more than 9 g of L-Arginine, per day.
Do not use if you have had a heart attack/myocardial infarction (Sun et al. 2009; Schulman et al. 2006; Bednarz et al. 2005).
Sources cited by Health Canada (3)
- Bednarz B, Jaxa-Chamiec T, Maciejewski P, Szpajer M, Janik K, Gniot J, Kawka-Urbanek T, Drozdowska D, Gessek J, Laskowski H. Efficacy and safety of oral L-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol Pol. 2005;62(5):421-427. PubMed Randomised trial
- Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G. L-Arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomised clinical trial. Journal of American Medical Association 2006;295(1):58-64. PubMed Randomised trial
- Sun T, Zhou WB, Luo XP, Tang YL, Shi HM. Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials. Clin Cardiol. 2009;32(11):649-652. PubMed Meta-analysis
Known adverse reactions
Applies to products providing more than 9 g of L-Arginine, per day.
When using this product you may experience gastrointestinal discomfort/disturbances (Grimble 2007; Evans et al. 2004; IOM 2005; Clarkson et al. 1996).
Sources cited by Health Canada (4)
- Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. Oral L-arginine endothelium-dependent dilation in hypercholesterolemic young adults. Journal of Clinical Investigation 1996;97(8):1989-1994. PubMed Randomised trial
- Evans WR, Fernstrom JD, Thompson J, Morris SM Jr, Kuller LH. Biochemical responses of healthy subjects during dietary supplementation with L-arginine. Journal of Nutritional Biochemistry 2004;15(9):534-539. PubMed
- Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. The Journal of Nutrition 2007;137(6 Suppl 2):1693S-1701S. PubMed Review article
- IOM 2005: Institute of Medicine. Panel on Dietary Reference Intakes for Electrolytes and Water, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington (DC): National Academies Press; 2005.
Texts from the monograph of Health Canada, the Canadian authority, reproduced without modification. They do not replace medical advice.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Health claims register (European Union): 0 authorised and 10 refused claim(s) for this substance.
EU Register of nutrition and health claims, retrieved 15 November 2026.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
Canada, licensed natural health products (LNHPD): 4 products.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
United States, supplement labels (DSLD; supplements need no prior approval): 362 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Malaysia, registered products: 3 products.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Poland, notified supplements: 2079 products.
GIS, products notified in Poland, retrieved 27 October 2026.
Główny Inspektorat Sanitarny (GIS), Rejestr produktów objętych powiadomieniem
Taiwan, registered products: 2 products.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
What we know about this ingredient
Associated research
ClinicalTrials.gov · A trial is not proof: it tests a hypothesis.
- NCT02447874 : Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
RECRUITING · PHASE1, PHASE2 · Sickle Cell Disease · 2026-07-29 · Arginine
- NCT06483737 : Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
RECRUITING · NA · Overt Hepatic Encephalopathy · 2025-08-26 · Arginine
- NCT05306925 : An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse
RECRUITING · NA · Preterm, Surgery, Nutritional Deficiency, Immune System and Related Disorders · 2026-02-18 · Arginine
Searched on 1 November 2026.
Scientific publications (PubMed)
18,045 records published in the five years before 12 November 2026. The name is searched in the title or abstract; derivatives and passing mentions can be counted. This count does not measure effectiveness.
Searched on 12 November 2026.
Most recent systematic reviews and meta-analyses:
- PMID 41424341. Nutritional supplements to improve esports player performance: a systematic review of randomized controlled trials. (2026, Journal of the International Society of Sports Nutrition)
- PMID 42548024. Lupus‑Associated Hypophysitis: A Narrative Systematic Review of Clinical, Radiological and Endocrine Features. (2026, Clinical endocrinology)
- PMID 42521111. A systematic review of genetic associations, autoantibody profiles, and research gaps of peptidyl arginine deiminases type 2 (PAD2) and PAD4 in rheumatoid arthritis. (2026, Autoimmunity reviews)
Products
Other related records
- CreaPlex Creatine Supplement from the US market
- GlutaPlex Glutamine Supplement from the US market
- Pure Protein Supplement from the US market
- Competitive Mass Supplement from the US market
- Horny Goat Weed 1600 : étiquette retirée du marché américain Supplement from the US market, 92617970029
- IntrAbolic Wild Berry Punch : étiquette retirée du marché américain Supplement from the US market
- IntrAbolic Blue Raspberry : étiquette retirée du marché américain Supplement from the US market
- Ultra Source of Life : étiquette retirée du marché américain Supplement from the US market
- Power Teen for Him Natural Wild Berry Flavor Supplement from the US market
- Ultra Source of Life Mini-Tabs : étiquette retirée du marché américain Supplement from the US market
- Ultra Source of Life No Iron Supplement from the US market, 97467305243
- Ultra Source of Life No Iron Supplement from the US market, 97467305267
- Source of Life Gold Drink Mix Delicious Tropical Fruit Flavor Supplement from the US market
- Source of Life Gold Mini-Tabs Supplement from the US market
- Gold Capsules : étiquette retirée du marché américain Supplement from the US market
- Chewables Delicious Tropical Fruit Flavor : étiquette retirée du marché américain Supplement from the US market
- Nutrient-Rich Chlorella Tablets Supplement from the US market
- Arginol Fusion Supplement from the US market
- Double Bonded Protein Chocolate Supplement from the US market
- MRP All Natural Meal-Replacement Shake Vanilla : étiquette retirée du marché américain Supplement from the US market
- MRP All Natural Meal-Replacement Shake Chocolate : étiquette retirée du marché américain Supplement from the US market
- All Natural Meal Replacement Shake Vanilla : étiquette retirée du marché américain Supplement from the US market
- Advanced Mineral Complex Plus Supplement from the US market
- Male Enhancement Supplement from the US market
- Total Amino Solution Supplement from the US market
- PowerMaker Supplement from the US market
- Beyond Tangy Tangerine Supplement from the US market
- Natural Amino Acids Complex : étiquette retirée du marché américain Supplement from the US market
- Veg-Pro Vanilla Cream Pie Supplement from the US market
- Collagen Hydrolysate Unflavored : étiquette retirée du marché américain Supplement from the US market
- Collagen Pure Unflavored Supplement from the US market
- Fade Out Grape Supplement from the US market
- All Plant Protein Powder : étiquette retirée du marché américain Supplement from the US market
- Nails : étiquette retirée du marché américain Supplement from the US market
- Whey Protein Vanilla Peanut Butter Supplement from the US market
- KH-6 Supplement from the US market
- AlphaMan XL Supplement from the US market
- Alive! Whole Food Energizer No Added Iron : étiquette retirée du marché américain Supplement from the US market
- Total Man Supplement from the US market
- Total Test Supplement from the US market, dsld-294261
- Xeno Amino Sour Berries Supplement from the US market
- Staminol Supplement from the US market
- Seismic6 Natural Citrus Twist Supplement from the US market
- Aminopowerplus Supplement from the US market
- Leanology Chocolate Supplement from the US market
- Male Fertility Support Supplement from the US market
- For Her Pink : étiquette retirée du marché américain Supplement from the US market
- Liquid Cell Energy Supplement from the US market
- Advanced Formula Hair, Skin & Nails : étiquette retirée du marché américain Supplement from the US market
- Amino2 Fruit Punch Supplement from the US market
- Amino2 Orange Supplement from the US market
- Male Reproductive Factors Supplement from the US market
- E & E Energy And Endurance Supplement from the US market
- VitaComplete Supplement from the US market